One-year remission of therapy-resistant SLE after a single course with the bispecific CD3: BCMA antibody teclistamab, but induction of a non-infectious Crohn’s-like inflammatory bowel disease - Lorenz, Hanns-Martin; Merkt, Wolfgang; Brandt, Juliane; Giese, Thomas; Exner, Tarik; Blank, Norbert; Souto-Carneiro, Maria Margarida; Gauss, Annika; Raab, Marc-Steffen (Annals of the rheumatic diseases, 2025)
Online verfügbar: 30. Mai 2025, Artikelversion: 4. Juli 2025